SNCA and Parkinson disease: High levels of α-synuclein have been reported in PD patients25 and increasing evidence shows how elevated intracellular calcium promotes α-synuclein aggregation26, while compromising calcium homeostasis and mitochondrial integrity probably due to soluble oligomer toxicity27.